Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2018 Filed Apr 2, 2018 22:26 UTC |
YOUNG JOHN DGroup President
|
GrantPhantom Stock Units SSP · Derivative | 11 | $35.49 | $390.39 |
DisclosureSEC source: 0001225208-18-006967 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,990 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 18:37 UTC |
BOURLA ALBERTDirector · Chief Operating Officer
|
GrantPhantom Stock Units SSP · Derivative | 524 | $36.58 | $19,167.92 |
DisclosureSEC source: 0001225208-18-006376 · doc4.xml · derivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,676 Underlying: Common Stock · 524 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 18:38 UTC |
JOHNSON RADY AExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 30 | $36.58 | $1,097.40 |
DisclosureSEC source: 0001225208-18-006377 · doc4.xml · derivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,413 Underlying: Common Stock · 30 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 18:38 UTC |
YOUNG JOHN DGroup President
|
GrantPhantom Stock Units SSP · Derivative | 216 | $36.58 | $7,901.28 |
DisclosureSEC source: 0001225208-18-006378 · doc4.xml · derivative · entry 1 YOUNG JOHN D · CIK 0001551792 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,978 Underlying: Common Stock · 216 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 13,900 | $36.94 | $513,466.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 14 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,857 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 5,500 | $36.93 | $203,115.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 13 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,757 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 4,600 | $36.92 | $169,832.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 12 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,257 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 4,413 | $36.85 | $162,619.05 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 11 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,857 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 4,100 | $36.87 | $151,167.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 10 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,270 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 3,700 | $36.78 | $136,086.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 9 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,370 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 2,575 | $36.86 | $94,914.50 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 8 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,070 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 2,440 | $36.89 | $90,011.60 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 7 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,645 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 2,300 | $36.88 | $84,824.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 6 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,085 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 1,800 | $36.90 | $66,420.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 5 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,385 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 1,572 | $36.77 | $57,802.44 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 4 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,185 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 1,300 | $36.84 | $47,892.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 3 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,757 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 1,000 | $36.80 | $36,800.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 2 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,057 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:13 UTC |
LANKLER DOUGLAS MExecutive Vice President
|
SaleCommon Stock | 800 | $36.81 | $29,448.00 |
DisclosureSEC source: 0001225208-18-006142 · doc4.xml · nonDerivative · entry 1 LANKLER DOUGLAS M · CIK 0001488270 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,057 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 7,000 | $36.55 | $255,850.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 10 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,178 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 3,800 | $36.54 | $138,852.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 9 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,178 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 3,200 | $36.58 | $117,056.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 8 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,978 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 3,100 | $36.53 | $113,243.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 7 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,178 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 2,854 | $36.56 | $104,342.24 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 6 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,278 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 2,700 | $36.52 | $98,604.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 5 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,132 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 2,200 | $36.60 | $80,520.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 4 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,832 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 1,600 | $36.51 | $58,416.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 3 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,032 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 700 | $36.57 | $25,599.00 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 2 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,632 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:19 UTC |
JOHNSON RADY AExecutive Vice President
|
SaleCommon Stock | 169 | $36.59 | $6,183.71 |
DisclosureSEC source: 0001225208-18-006156 · doc4.xml · nonDerivative · entry 1 JOHNSON RADY A · CIK 0001594762 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,332 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 32,457 | $36.61 | $1,188,250.77 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 7 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,185 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 15,459 | $36.56 | $565,181.04 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 6 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,642 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 9,900 | $36.60 | $362,340.00 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 5 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,101 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 5,300 | $36.59 | $193,927.00 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 4 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,001 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 4,154 | $36.57 | $151,911.78 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 3 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,301 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 2,329 | $36.55 | $85,124.95 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 2 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,455 Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 21:01 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 100 | $36.58 | $3,658.00 |
DisclosureSEC source: 0001225208-18-005928 · doc4.xml · nonDerivative · entry 1 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,784 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC |
HILL CHARLES HExecutive Vice President
|
SaleCommon Stock | 30,539 | $35.78 | $1,092,685.42 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 5 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,328 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC |
HILL CHARLES HExecutive Vice President
|
SaleCommon Stock | 10,715 | $35.70 | $382,525.50 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 4 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,867 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC |
HILL CHARLES HExecutive Vice President
|
SaleCommon Stock | 493 | $35.79 | $17,644.47 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 3 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,582 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC |
HILL CHARLES HExecutive Vice President
|
SaleCommon Stock | 330 | $35.80 | $11,814.00 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 2 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,075 Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:09 UTC |
HILL CHARLES HExecutive Vice President
|
SaleCommon Stock | 316 | $35.81 | $11,315.96 |
DisclosureSEC source: 0001225208-18-005645 · doc4.xml · nonDerivative · entry 1 HILL CHARLES H · CIK 0001508517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,405 Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 21:07 UTC |
LITTMAN DAN R.Director
|
GrantPhantom Stock Units · Derivative | 5,191.03 | $36.12 | $187,500.00 |
DisclosureSEC source: 0001225208-18-005412 · doc4.xml · derivative · entry 1 LITTMAN DAN R. · CIK 0001733004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,191.03 Underlying: Common Stock · 5,191.03 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 14:23 UTC |
Dolsten MikaelPresident R&D
|
SaleCommon Stock | 13,986 | $35.85 | $501,398.10 |
DisclosureSEC source: 0001225208-18-005203 · doc4.xml · nonDerivative · entry 1 Dolsten Mikael · CIK 0001437590 · President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,884 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
BOURLA ALBERTDirector · Chief Operating Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 39,923 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-18-005094 · doc4.xml · derivative · entry 5 BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,923 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
BOURLA ALBERTDirector · Chief Operating Officer
|
Tax withholdingCommon Stock | 24,233 | $35.70 | $865,118.10 |
DisclosureSEC source: 0001225208-18-005094 · doc4.xml · nonDerivative · entry 3 BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,689 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
BOURLA ALBERTDirector · Chief Operating Officer
|
Tax withholdingCommon Stock | 6,198 | $36.31 | $225,049.38 |
DisclosureSEC source: 0001225208-18-005094 · doc4.xml · nonDerivative · entry 2 BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,922 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
BOURLA ALBERTDirector · Chief Operating Officer
|
Exercise / conversionCommon Stock | 39,923 | $27.37 | $1,092,692.51 |
DisclosureSEC source: 0001225208-18-005094 · doc4.xml · nonDerivative · entry 1 BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Exercise / conversionStock Appreciation Rights · Derivative | 33,040 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · derivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,040 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 20,055 | $35.70 | $715,963.50 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,433 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Tax withholdingCommon Stock | 6,359 | $36.31 | $230,895.29 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,488 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:24 UTC |
CANGIALOSI LORETTA VSr. Vice President, Controller
|
Exercise / conversionCommon Stock | 33,040 | $27.37 | $904,304.80 |
DisclosureSEC source: 0001225208-18-005095 · doc4.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.